{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:14:03Z","timestamp":1785428043667,"version":"3.56.0"},"reference-count":50,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R01GM112490-08; 1R01GM130091-05"],"award-info":[{"award-number":["1R01GM112490-08; 1R01GM130091-05"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"award":["1R01GM112490-08; 1R01GM130091-05"],"award-info":[{"award-number":["1R01GM112490-08; 1R01GM130091-05"]}],"id":[{"id":"https:\/\/ror.org\/04q48ey07","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["D-0005"],"award-info":[{"award-number":["D-0005"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"award":["D-0005"],"award-info":[{"award-number":["D-0005"]}],"id":[{"id":"https:\/\/ror.org\/00np6vq88","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001027","name":"The CH Foundation","doi-asserted-by":"crossref","award":["no number"],"award-info":[{"award-number":["no number"]}],"id":[{"id":"10.13039\/100001027","id-type":"DOI","asserted-by":"crossref"}]},{"award":["no number"],"award-info":[{"award-number":["no number"]}],"id":[{"id":"https:\/\/ror.org\/05nnhd665","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder traditionally defined by dopaminergic neuronal loss and Lewy body pathology; however, increasing evidence indicates that metabolic dysfunction contributes to both motor and non-motor manifestations of disease. While metabolomics studies in PD have largely focused on peripheral biofluids or subcortical brain regions, metabolic remodeling within cortical regions critical for cognition remains poorly characterized. Here, we applied LC-MS\/MS-based untargeted metabolomics to post-mortem frontal cortex tissue from PD and neurologically normal control donors, with statistical models adjusted for age, sex, and post-mortem interval. A total of 893 metabolites were quantified, of which 234 exhibited significant differential abundance following false discovery rate correction. Pathway enrichment and network-based integration revealed coordinated metabolic remodeling characterized by predicted inhibition of \u03b2-alanine metabolism and pantothenate-dependent coenzyme A biosynthesis alongside activation of amino acid, vitamin B-dependent, cofactor-related, redox-associated, oxidative stress, and inflammatory pathways. Recurrent alterations in pantothenic acid, \u03b2-alanine-related intermediates, arginine- and histidine-derived metabolites, lumichrome, and vitamin B6-associated species may reflect cortical metabolic perturbations associated with mitochondrial bioenergetic vulnerability and oxidative stress. Together, these findings indicate selective metabolic vulnerability in the PD frontal cortex rather than diffuse metabolic collapse.<\/jats:p>","DOI":"10.3390\/biom16060866","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:49:42Z","timestamp":1781743782000},"page":"866","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic Remodeling of the Parkinson\u2019s Disease Frontal Cortex Revealed by LC-MS\/MS Metabolomics"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0394-3683","authenticated-orcid":false,"given":"Oluwatosin","family":"Daramola","sequence":"first","affiliation":[{"name":"Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7885-1345","authenticated-orcid":false,"given":"Judith","family":"Nwaiwu","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7291-044X","authenticated-orcid":false,"given":"Odunayo","family":"Oluokun","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9168-5396","authenticated-orcid":false,"given":"Mojibola","family":"Fowowe","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Lux","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5877-2163","authenticated-orcid":false,"given":"Andrew I.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-6073","authenticated-orcid":false,"given":"Yehia","family":"Mechref","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX 79409, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13024-021-00425-8","article-title":"Comprehensive metabolic profiling of Parkinson\u2019s disease by liquid chromatography-mass spectrometry","volume":"16","author":"Shao","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/acsomega.4c09114","article-title":"Evolving Landscape of Parkinson\u2019s Disease Research: Challenges and perspectives","volume":"10","author":"Tenchov","year":"2025","journal-title":"ACS Omega"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"5","author":"Breteler","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"105585","DOI":"10.1016\/j.ebiom.2025.105585","article-title":"Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: Medication use, health conditions, and biomarkers associated with Alzheimer\u2019s disease, Parkinson\u2019s disease, and amyotrophic lateral sclerosis","volume":"113","author":"Wei","year":"2025","journal-title":"eBioMedicine"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: Clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.37349\/ent.2023.00036","article-title":"Pathophysiology of non-motor signs in Parkinsons disease: Some recent updating with brief presentation","volume":"3","author":"Radad","year":"2023","journal-title":"Explor. Neuroprot. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson\u2019s disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol. Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease\u2014A key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1007\/s10072-021-05551-1","article-title":"A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"42","author":"Mani","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fnins.2019.00457","article-title":"Dysfunction of cellular proteostasis in Parkinson\u2019s disease","volume":"13","author":"Lehtonen","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Putcha, D., Jaywant, A., and Cronin-Golomb, A. (2016). Cognitive and perceptual impairments in Parkinson\u2019s disease arising from dysfunction of the cortex and basal ganglia. The Basal Ganglia: Novel Perspectives on Motor and Cognitive Functions, Springer.","DOI":"10.1007\/978-3-319-42743-0_9"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/ejn.15899","article-title":"Hippocampal, basal ganglia and olfactory connectivity contribute to cognitive impairments in Parkinson\u2019s disease","volume":"57","author":"Wylie","year":"2023","journal-title":"Eur. J. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e2107022118","DOI":"10.1073\/pnas.2107022118","article-title":"Brain power","volume":"118","author":"Balasubramanian","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41583-021-00535-8","article-title":"Energy matters: Presynaptic metabolism and the maintenance of synaptic transmission","volume":"23","author":"Li","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fneur.2013.00199","article-title":"Synaptic activity and bioenergy homeostasis: Implications in brain trauma and neurodegenerative diseases","volume":"4","author":"Khatri","year":"2013","journal-title":"Front. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1039\/D0MO00176G","article-title":"Metabolomics: Small molecules that matter more","volume":"17","author":"Muthubharathi","year":"2021","journal-title":"Mol. Omics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2013.06.014","article-title":"Recent advances in the application of metabolomics to Alzheimer\u2019s Disease","volume":"1842","author":"Trushina","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"106672","DOI":"10.1016\/j.nbd.2024.106672","article-title":"Metabolic dysregulation in Huntington\u2019s disease: Neuronal and glial perspectives","volume":"201","author":"Chang","year":"2024","journal-title":"Neurobiol. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"34236","DOI":"10.1038\/s41598-025-16220-0","article-title":"Exploring platelet metabolomics and fatty acid profiles for ALS prognosis and diagnosis","volume":"15","author":"Torres","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Daramola, O., Gutierrez Reyes, C.D., Ch\u00e1vez-Reyes, J., Marichal-Cancino, B.A., Nwaiwu, J., Onigbinde, S., Adeniyi, M., Solomon, J., Bhuiyan, M., and Mechref, Y. (2024). Metabolomic Changes in Rat Serum after Chronic Exposure to Glyphosate-Based Herbicide. Metabolites, 14.","DOI":"10.3390\/metabo14010050"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e01520","DOI":"10.1002\/brb3.1520","article-title":"Metabolomics analysis of the hippocampus in a rat model of traumatic brain injury during the acute phase","volume":"10","author":"Zheng","year":"2020","journal-title":"Brain Behav."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/toxsci\/kfi102","article-title":"Metabonomics in toxicology: A review","volume":"85","author":"Robertson","year":"2005","journal-title":"Toxicol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"117771","DOI":"10.1016\/j.biopha.2024.117771","article-title":"Positive impact of DPP-4 or SGLT2 inhibitors on mild cognitive impairment in type 2 diabetes patients on metformin therapy: A metabolomic mechanistic insight","volume":"182","author":"Osman","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41531-023-00531-y","article-title":"Targeted metabolomic analysis in Parkinson\u2019s disease brain frontal cortex and putamen with relation to cognitive impairment","volume":"9","author":"Bottiglieri","year":"2023","journal-title":"npj Park. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41531-025-01126-5","article-title":"Independent serum metabolomics approaches identify disrupted glutamic acid and serine metabolism in Parkinson\u2019s disease patients","volume":"11","author":"Gervasoni","year":"2025","journal-title":"npj Park. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Ostrakhovitch, E.A., Ono, K., and Yamasaki, T.R. (2025). Metabolomics in Parkinson\u2019s Disease and Correlation with Disease State. Metabolites, 15.","DOI":"10.3390\/metabo15030208"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4939-9488-5_19","article-title":"Metabolomics Analyses from Tissues in Parkinson\u2019s Disease","volume":"1996","author":"Bhinderwala","year":"2019","journal-title":"Metabolomics Methods Protoc."},{"key":"ref_29","unstructured":"Daramola, O., and Mechref, Y. (MetaboGraph: A Framework for Metabolomics and Lipidomics Annotation and Pathway Network Analysis, 2026). MetaboGraph: A Framework for Metabolomics and Lipidomics Annotation and Pathway Network Analysis, Ver. 1.0.1."},{"key":"ref_30","unstructured":"Daramola, O., and Mechref, Y. (OmicsVisStat: Statistical and Visualization Platform for Omics Data Analysis, 2026). OmicsVisStat: Statistical and Visualization Platform for Omics Data Analysis, v1.0."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: Mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","article-title":"Premotor and nonmotor features of Parkinson\u2019s disease","volume":"27","author":"Goldman","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5607\/en.2015.24.2.103","article-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease","volume":"24","author":"Moon","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson\u2019s disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1423-0127-16-63","article-title":"Metabolic profiling of Parkinson\u2019s disease: Evidence of biomarker from gene expression analysis and rapid neural network detection","volume":"16","author":"Ahmed","year":"2009","journal-title":"J. Biomed. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","article-title":"Recent advances and perspectives of metabolomics-based investigations in Parkinson\u2019s disease","volume":"14","author":"Shao","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_40","first-page":"965","article-title":"Localized Pantothenic Acid (Vitamin B5) Reductions Present Throughout the Dementia with Lewy Bodies Brain","volume":"14","author":"Scholefield","year":"2024","journal-title":"J. Park. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41531-024-00732-z","article-title":"Identification of metabolites reproducibly associated with Parkinson\u2019s Disease via meta-analysis and computational modelling","volume":"10","author":"Luo","year":"2024","journal-title":"npj Park. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"16768","DOI":"10.1074\/jbc.M601876200","article-title":"Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption","volume":"281","author":"Soga","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Scholefield, M., Church, S.J., Xu, J., Patassini, S., Hooper, N.M., Unwin, R.D., and Cooper, G.J.S. (2021). Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson\u2019s Disease Dementia. Metabolites, 11.","DOI":"10.3390\/metabo11090569"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/JAD-2007-11210","article-title":"Could carnosine or related structures suppress Alzheimer\u2019s disease?","volume":"11","author":"Hipkiss","year":"2007","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1152\/physrev.00039.2012","article-title":"Physiology and pathophysiology of carnosine","volume":"93","author":"Boldyrev","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_46","first-page":"606","article-title":"Assessment of the Relationship Between Amino Acid Status and Parkinson\u2019s Disease: A Comprehensive Review and Meta-analysis","volume":"52","author":"Akdas","year":"2024","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1608031","DOI":"10.3389\/fneur.2025.1608031","article-title":"Metabolomic profiling uncovers diagnostic biomarkers and dysregulated pathways in Parkinson\u2019s disease","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Neurol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1017\/S0007114510001005","article-title":"Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson\u2019s disease: A case-control study in Japan","volume":"104","author":"Murakami","year":"2010","journal-title":"Br. J. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/WNF.0000000000000408","article-title":"Vitamin B6 Deficiency in Patients with Parkinson Disease Treated with Levodopa\/Carbidopa","volume":"43","year":"2020","journal-title":"Clin. Neuropharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0304-3940(86)90320-4","article-title":"Idiopathic Parkinson\u2019s disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients","volume":"67","author":"Perry","year":"1986","journal-title":"Neurosci. Lett."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/6\/866\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:22:15Z","timestamp":1781842935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/6\/866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["biom16060866"],"URL":"https:\/\/doi.org\/10.3390\/biom16060866","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]}}}